These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4371994)

  • 1. Adolescent hypertension. II. Characteristics and response to treatment.
    Kilcoyne MM
    Circulation; 1974 Nov; 50(5):1014-9. PubMed ID: 4371994
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of hypertension in the black population.
    Kilcoyne MM; Thomson GE; Branche G; Williams M; Garnier C; Chiles B; Soland T
    Circulation; 1974 Nov; 50(5):1006-13. PubMed ID: 4371993
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of severe hypertension.
    Kincaid-Smith P
    Am J Cardiol; 1973 Sep; 32(4):575-81. PubMed ID: 4147110
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison between spironolactone and hydrochlorothiazide with and without alpha-methyldopa in the treatment of hypertension.
    Walter NM; Suthers MB; Friedman A; Johnston CI
    Med J Aust; 1978 May; 1(9):509-12. PubMed ID: 353458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 6. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):60-1. PubMed ID: 1071406
    [No Abstract]   [Full Text] [Related]  

  • 7. [New trends in the diagnosis, prognosis and treatment of hypertension].
    Sova J
    Vnitr Lek; 1974 Mar; 20(3):209-18. PubMed ID: 4822996
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.
    Karlberg BE; Kågedal B; Tegler L; Tolagen K; Bergman B
    Am J Cardiol; 1976 Mar; 37(4):642-9. PubMed ID: 769527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combination of propranolol and hydralazine versus alpha-methyldopa in hypertension.
    Chopra BK
    J Assoc Physicians India; 1984 Sep; 32(9):811. PubMed ID: 6511772
    [No Abstract]   [Full Text] [Related]  

  • 10. Workup and treatment of the average hypertensive patient.
    Finnerty FA
    Compr Ther; 1978 Dec; 4(12):40-5. PubMed ID: 738011
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].
    Káldor A; Kállay K; Sebestyén K; Alexits K
    Orv Hetil; 1972 Jan; 113(1):23-4. PubMed ID: 4333395
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug combinations in the treatment of primary arterial hypertension].
    Angelino PF
    Minerva Med; 1975 Feb; 66(13):602-11. PubMed ID: 1113910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of hypertension.
    Rick JH; Oparil S
    Compr Ther; 1977 May; 3(5):34-46. PubMed ID: 16723
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs used in the treatment of hypertension.
    Finnerty FA
    Mod Concepts Cardiovasc Dis; 1973 Jul; 42(7):33-6. PubMed ID: 4786758
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency.
    Lowenstein I; Alterman L; Zelen R; Bank DE; Bank N
    J Clin Pharmacol; 1984 Oct; 24(10):436-45. PubMed ID: 6392352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential therapeutic principles in the drug therapy of high blood pressure].
    Rahn KH
    Internist (Berl); 1974 Mar; 15(3):157-64. PubMed ID: 4151964
    [No Abstract]   [Full Text] [Related]  

  • 17. Sympathetic nervous function and renin activity in hypertensives on long term drug treatment with propranolol, methyldopa or bendrofluazide.
    Polak G; Reid JL; Hamilton CA; Jones DH; Dollery CT
    Clin Exp Hypertens (1978); 1978; 1(1):1-9. PubMed ID: 755641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of pathophysiology and pharmacotherapy in primary hypertension.
    Koch-Weser J
    Am J Cardiol; 1973 Sep; 32(4):499-510. PubMed ID: 4593182
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic combinations, side effects and interactions of antihypertensive drugs].
    Angelino PF
    Minerva Cardioangiol; 1976 Jun; 24(6):456-64. PubMed ID: 1012494
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess.
    Lebel M; Schalekamp MA; Beevers DG; Brown JJ; Davies DL; Fraser R; Kremer D; Lever AF; Morton JJ; Robertson JI; Tree M; Wilson A
    Lancet; 1974 Aug; 2(7876):308-9. PubMed ID: 4136047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.